GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Origin Therapeutics Holdings Inc (XCNQ:ORIG) » Definitions » YoY EBITDA Growth

Origin Therapeutics Holdings (XCNQ:ORIG) YoY EBITDA Growth : 50.00% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Origin Therapeutics Holdings's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was 50.00%.

Origin Therapeutics Holdings's EBITDA per Share for the three months ended in Jun. 2023 was C$-0.00.


Origin Therapeutics Holdings YoY EBITDA Growth Historical Data

The historical data trend for Origin Therapeutics Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings YoY EBITDA Growth Chart

Origin Therapeutics Holdings Annual Data
Trend Sep21 Sep22
YoY EBITDA Growth
- -

Origin Therapeutics Holdings Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only -300.00 -150.00 50.00 - 50.00

Origin Therapeutics Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Origin Therapeutics Holdings's YoY EBITDA Growth for the fiscal year that ended in Sep. 2022 is calculated as:

YoY EBITDA Growth (A: Sep. 2022 )
=(EBITDA per Share (A: Sep. 2022 )-EBITDA per Share (A: Sep. 2021 ))/ | EBITDA per Share (A: Sep. 2021 ) |
=(-0.018-0)/ | 0 |
=N/A %

Origin Therapeutics Holdings's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (Q: Jun. 2023 )
=(EBITDA per Share (Q: Jun. 2023 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(-0.002--0.004)/ | -0.004 |
=50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Origin Therapeutics Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Origin Therapeutics Holdings (XCNQ:ORIG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
505 Burrard Street, Suite 1570, Vancouver, BC, CAN, V7X 1M5
Origin Therapeutics Holdings Inc is an investment company focusing on investments in the psychedelic industry.